PharmacoEconomics

Accounting for Tastes: A German Perspective on the Inclusion of Patient Preferences in Healthcare
pp. 419-423(5)
Authors: Vogt, Florian; Schwappach, David L.B.; Bridges, John F.P.

Cost Effectiveness of Preventive Interventions in Type 2 Diabetes Mellitus: A Systematic Literature Review
pp. 425-441(17)
Authors: Vijgen, Sylvia M.C.; Hoogendoorn, Mirjam; Baan, Caroline A.; G. Ardine de Wit,; Limburg, Wien; Feenstra, Talitha L.

Cost Effectiveness of Increasing the Dose Intensity of Chemotherapy with Granulocyte Colony-Stimulating Factor in Small-Cell Lung Cancer: Based on Data from the Medical Research Council LU19 Trial
pp. 443-452(10)
Authors: Bojke, Laura; Sculpher, Mark; Stephens, Richard; Qian, Wendi; Thatcher, Nick; Girling, David

Encouraging Smokers to Quit: The Cost Effectiveness of Reimbursing the Costs of Smoking Cessation Treatment
pp. 453-464(12)
Authors: Kaper, Janneke; Wagena, Edwin J.; van Schayck, Constant P.; Severens, Johan L.

Comprehensive Decision-Analytic Model and Bayesian Value-of-Information Analysis: Pentoxifylline in the Treatment of Chronic Venous Leg Ulcers
pp. 465-478(14)
Authors: Iglesias, Cynthia P.; Claxton, Karl

Economic Evaluation of Weekly Epoetin Alfa versus Biweekly Darbepoetin Alfa for Chemotherapy-Induced Anaemia: Evidence from a 16-Week Randomised Trial
pp. 479-494(16)
Authors: Reed, Shelby D.; Radeva, Jasmina I.; Daniel, Davey B.; Mody, Samir H.; Forlenza, Jamie B.; McKenzie, R. Scott; Schulman, Kevin A.

Letrozole: A Pharmacoeconomic Review of its Use in Postmenopausal Women with Breast Cancer
pp. 495-517(23)
Authors: Dunn, Christopher; Keam, Susan J.

Cost Considerations in the Medical Management of Glaucoma in the US: Estimated Yearly Costs and Cost Effectiveness of Bimatoprost Compared with Other Medications
pp. 519-520(2)
Author: Soto, Javier

The Authors' Reply
pp. 520-522(3)
Authors: Goldberg, Lawrence D.; Walt, John G.